drugset / Trial / NCT00860808

Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus

NCT00860808

Phase 2 Completed 248 enrolled Auris Medical AG
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is the evaluation of the therapeutic benefit of intratympanic AM 101 injections in comparison to placebo in the treatment of persistent acute inner ear tinnitus following acute sensorineural hearing loss.

Timeline

Start
2009-03
Primary completion
2011-05
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified Intrathecal

Indications